Aquyre News

Aquyre Biosciences wins top award from French American Chamber of Commerce, New England

Aquyre Biosciences announces appointment of F. Samuel Eberts III as CEO and Chairman of the Board of Directors | Founder Bertrand de Poly as Chief Strategy & Technology Officer

Aquyre Biosciences to present at this year’s Biotech Showcase | Data from Biopsies, 2-Minutes in the Operating Room

Dr. Stephen Kovacs discusses how how he uses CelTivity at UPMC Hamot

New technology at UPMC Hamot - Learn how Dr. Kovacs uses this game changing technology

Aquyre Biosciences Reaches Major Procedure Milestone During Lung Awareness Month

Aquyre Biosciences, Inc. Appoints Dr. Wilson Tsai to its Medical Advisory Board

Contact us today

Interested in learning more about Van Gogh?

Testimonials

Dr. Wilson Tsai

Director, Thoracic Program, John Muir Health

“Easy shot with EBUS with obvious confirmation of tool in lesion…. ROSE did not show lymphocytes, but CelTivity did! …”

Dr. Michael Pritchett

Director, Chest Center of the Carolinas at FirstHealth

“This technology may improve diagnostic yield, improve adequacy assessment and allows the proceduralist to process and interpret their own biopsies…”

Dr. Stephen Kovacs

Chief, Division of Pulmonary Medicine at UPMC Hamot

“Utilizing CelTivity during our robotic bronchoscopic cases has been a game changer for diagnosis…”

Dr. Ismael Matus

Director of Interventional Pulmonology at ChristianaCare

"This ultimately empowered the proceduralist with information that made the difference between a diagnostic and a non-diagnostic bronchoscopy."

01 — 00

Contact Us

Aquyre Biosciences, Inc is the industry leader in two-minute lung biopsy adequacy assessment by digitally measuring intracellular and metabolic activity throughout extracted tissue.

Contact

Aquyre BioSciences, Inc.
133 Boston Post Road
Weston, MA 02493

+1 (774)-220-7040

info@aquyre.com

General

Clinical Images

About

Legal

Social

© 2023 Aquyre BioSciences, Inc. All Rights Reserved